Since our inception, Croft Investments
has been focused on building a strategic "Calculated Risk" Methodology.
Our Family Office, Croft Investments Limited Partnership, was formed in January 2002 to invest the funds of our principals. Since that time, we have focused on industry segments that show leading edge capabilities, and the possibility for significant upside. Although there is an element of the Family’s investments which follow a conservative approach, Croft was formed to take the “calculated risk” portion of the portfolio.
To date our investments have been in a diversified group of companies, and in most cases we are minority investors. We rely on experienced management to handle the business in an industry they know, and we back them and their partners by giving them access to strategic growth capital, and occasionally some advice as well. Our role, however, is as an principal investor.
Industries we are presently pursuing include:
Medical products (technologically advance and innovative);
Business to business services;
Manufacturing of products that are cutting edge;
Biotech which is cutting edge, where there are significant other institutional and family office investors;
Undervalued commercial real estate in the Southeast USA.
Hotel opportunities both domestical and international
Our preference is for our portfolio companies to have revenues and be cash flow positive, with our capital allowing for a jumpstart that is needed to reach the next level. However, we will look at pre revenue and pre profit companies and we have been quite successful in a number of startup businesses in the past.
Chief Investment Officer
Mr. Barbarosh is a Florida licensed CPA; a member of the AICPA and FICPA; a licensed business valuator with accredited as an ABV through the AICPA, and a Senior Member of the American Society of Appraisers in Business Valuation; and President of Stenton Leigh Valuation Group, Inc. a Florida license CPA firm